Open AccessAssociation Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes
Author(s) -
Anna R. Kahkoska,
Trine Julie Abrahamsen,
G. Caleb Alexander,
Tellen D. Bennett,
Christopher G. Chute,
Melissa Haendel,
Klara R. Klein,
Hemalkumar B. Mehta,
Joshua D. Miller,
Richard A. Moffitt,
Til Stürmer,
Kajsa Kvist,
John B. Buse
Publication year - 2021
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/1yfd-sc03
Subject(s) - glucagon like peptide 1 receptor , glucagon like peptide 1 , agonist , covid-19 , endocrinology , receptor , chemistry , medicine , pharmacology , diabetes mellitus , type 2 diabetes , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom